Glutamate and antimitotic agents induce differentiation, p53 activation, and apoptosis in rodent neostriatal cell lines immortalized with the tsA58 allele of SV40 large T antigen

Experimental Neurology

Volumn 158, Issue 1, 1999, Pages 109-120

  Conejero, Concepcion ^a   Wright, Renee ^a   Freed, William ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Apoptosis p53; Cell lines; PC12 cell; SV40 large T antigen

Indexed keywords

ANTIMITOTIC AGENT; CYTARABINE; DOXORUBICIN; GLUTAMIC ACID; PROTEIN P53; VIRUS LARGE T ANTIGEN;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; GROWTH REGULATION; NEOSTRIATUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; TEMPERATURE SENSITIVITY;

EID: 0032866259     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7083     Document Type: Article

References (90)

1. Aller P., Rius C., Mata F., Zorrilla A., Cabanas C., Bellon T., Bernabeu C. Camptothecin induces differentiation and stimulates the expression of differentiation-related genes in U-937 human promonocytic leukemia cells. Cancer Res. 52:1992;1245-1251.
2. Anton R., Kordower J. H., Maidment N. T., Manaster J. S., Kane D. J., Rabizadeh S., Schueller S. B., Yang J., Rabizadeh S., Edwards R. H., Markham C. H., Bredesen D. E. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp. Neurol. 127:1994;207-218.
3. Barlogie B., Drewinko B., Johnston D. A., Freireich E. J. The effect of Adriamycin on the cell cycle traverse of a human lymphoid cell line. Cancer Res. 36:1976;1975-1979.
4. Barnard J. A., Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ. 4:1993;495-501.
5. Bellamy W. T., Dalton W. S., Kailey J. M., Gleason M. C., McCloskey T. M., Dorr R. T., Alberts D. S. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Cancer Res. 48:1988;6365-6370.
6. Bianchi Scarra G. L., Romani M., Coviello D. A., Garre C., Ravazzolo R., Vidali G., Ajmar F. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: Accompaniment by c-myc messenger RNA decrease. Cancer Res. 46:1986;6327-6332.
7. Billon N., van Grunsven L. A., Rudkin B. B. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene. 13:1996;2047-2054.
8. Brambilla E., Moro D., Gazzeri S., Brichon P. Y., Nagy-Mignotte H., Morel F., Jacrot M., Brambilla C. Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J. Clin. Oncol. 9:1991;50-61.
9. Bustamante J., Galleano M., Medrano E. E., Boveris A. Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells. Breast Cancer Res. Treat. 17:1990;145-153.
10. Constantinou A., Kiguchi K., Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50:1990;2618-2624.
11. Cummings J., Anderson L., Willmott N., Smyth J. F. The molecular pharmacology of doxorubicin in vivo. Eur. J. Cancer. 27:1991;532-535.
12. Dessi F., Pollard H., Moreau J., Ben-Ari Y., Charriaut-Marlangue C. Cytosine arabinoside induces apoptosis in cerebellar neurons in culture. J. Neurochem. 64:1995;1980-1987.
13. Dillon-Carter O., Conejero C., Tornatore C., Poltorak M., Freed W. N18-RE-105 cells: Differentiation and activation of p53 in response to glutamate and Adriamycin is blocked by SV40 large T antigen tsA58. Cell Tissue Res. 291:1998;191-205.
14. Dyson N., Bernards R., Friend S. H., Gooding L. R., Hassell J. A., Major E. O., Pipas J. M., Vandyke T., Harlow E. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol. 64:1990;1353-1356.
15. el-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y. S., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
16. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
17. Elledge R. M., Lee W. H. Life and death by p53. Bioessays. 17:1995;923-930.
18. Eves E. M., Tucker M. S., Roback J. D., Downen M., Rosner M. R., Wainer B. H. Immortal rat hippocampal cell lines exhibit neuronal and glial lineages and neurotrophin gene expression. Proc. Natl. Acad. Sci. USA. 89:1992;4373-4377.
19. Evrard C., Borde I., Marin P., Galiana E., Premont J., Gros F., Rouget P. Immortalization of bipotential and plastic glio-neuronal precursor cells. Proc. Natl. Acad. Sci. USA. 87:1990;3062-3066.
20. Feinstein E., Gale R. P., Reed J., Canaani E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene. 7:1992;1853-1857.
21. Fisher G. R., Patterson L. H. Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: Comparison with doxorubicin. Cancer Chemother. Pharmacol. 30:1992;451-458.
22. Fornari F. A., Randolph J. K., Yalowich J. C., Ritke M. K., Gewirtz D. A. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol. Pharmacol. 45:1994;649-656.
23. Fornari F. A. Jr., Jarvis W. D., Grant S., Orr M. S., Randolph J. K., White F. K., Mumaw V. R., Lovings E. T., Freeman R. H., Gewirtz D. A. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. Cell Growth Differ. 5:1994;723-733.
24. Frederiksen K., Thorpe A., Richards S. J., Waters J., Dunnett S. B., Sandberg B. E. Immortalized neural cells from trisomy 16 mice as models for Alzheimer's disease. Ann. N.Y. Acad. Sci. 777:1996;415-420.
25. Frederiksen K., Jat P. S., Valtz N., Levy D., McKay R. Immortalization of precursor cells from the mammalian CNS. Neuron. 1:1988;439-448.
26. Frisa P. S., Goodman M. N., Smith G. M., Silver J., Jacobberger J. W. Immortalization of immature and mature mouse astrocytes with SV40 T antigen. J. Neurosci. Res. 39:1994;47-56.
27. Gamba-Vitalo C., Blair O. C., Tritton T. R., Lane P. A., Carbone R., Sartorelli A. C. Cytotoxicity and differentiating actions of adriamycin in WEHI-3B D+ leukemia cells. Leukemia. 1:1987;188-197.
28. Geller H. M., Dubois-Dalcq M. Antigenic and functional characterization of a rat central nervous system-derived cell line immortalized by a retroviral vector. J. Cell. Biol. 107:1988;1977-1986.
29. Giordano M., Takashima H., Herranz A., Poltorak M., Geller H. M., Marone M., Freed W. J. Immortalized GABAergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV40 large T antigen. Exp. Neurol. 124:1993;395-400.
30. Giordano M., Takashima H., Poltorak M., Geller H. M., Freed W. J. Constitutive expression of glutamic acid decarboxylase (GAD) by striatal cell lines immortalized using the tsA58 allele of the SV40 large T antigen. Cell Transplant. 5:1996;563-575.
31. Goldenberg G. J., Wang H., Blair G. W. Resistance to Adriamycin: Relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res. 46:1986;2978-2983.
32. Gotz C., Montenarh M. p53: DNA damage, DNA repair, and apoptosis. Rev. Physiol. Biochem. Pharmacol. 127:1996;65-95.
33. Hass R., Gunji H., Datta R., Kharbanda S., Hartmann A., Weichselbaum R., Kufe D. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. Cancer Res. 52:1992;1445-1450.
34. Hisanaga K., Kure S., Bredesen D. E., Ikeda Y., Kohsaka S., Sharp F. R. Apoptotic cell death of a temperature-sensitive central neuronal cell line. Brain Res. 684:1995;79-86.
35. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 253:1991;49-53.
36. Hozumi M. Fundamentals of chemo-differentiation therapy of myeloid leukemia. Anticancer Res. 14:1994;1177-1192.
37. Jat P. S., Sharp P. A. Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol. Cell. Biol. 9:1989;1672-1681.
38. Johnson P., Chung S., Benchimol S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13:1993;1456-1463.
39. Kastan M. B., Radin A. I., Kuerbitz S. J., Onyekwere O., Wolkow C. A., Civin C. I., Stone K. D., Woo T., Ravindranath Y., Craig R. W. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 51:1991;4279-4286.
40. Koeffler H. P. Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications. Blood. 62:1983;709-721.
41. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
42. Kure S., Tominaga T., Yoshimoto T., Tada K., Narisawa K. Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun. 179:1991;39-45.
43. Kwok T. T., Mok C. H., Menton-Brennan L. Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells. Cancer Res. 54:1994;2834-2836.
44. Lane D. P., Crawford L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278:1979;261-263.
45. Lanks K. W., Lehman J. M. DNA synthesis by L929 cells following doxorubicin exposure. Cancer Res. 50:1990;4776-4778.
46. Lill N. L., Grossman S. R., Ginsberg D., DeCaprio J., Livingston D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature. 387:1997;823-827.
47. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
48. Ludlow J. W. Use of sequential immunoprecipitation to reveal discrete, separable populations of SV40 T-antigen binding to host cellular proteins. J. Virol. Methods. 59:1996;105-112.
49. Major E. O., Miller A. E., Mourrain P., Traub R. G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. USA. 82:1985;1257-1261.
50. Mariani M., Supino R. Morphological alterations induced by doxorubicin in B16 melanoma cells. Cancer Lett. 51:1990;209-212.
51. Marks P. A., Sheffery M., Ramsay R., Ikeda K., Rifkind R. A. Induction of transformed cells to terminal differentiation. Ann. N.Y. Acad. Sci. 511:1987;246-255.
52. Marks P. A., Rifkind R. A. Erythroleukemic differentiation. Annu. Rev. Biochem. 47:1978;419-448.
53. Marone M., Quinones-Jenab V., Meiners S., Nowakowski R. S., Ho S. Y., Geller H. M. An immortalized mouse neuroepithelial cell line with neuronal and glial phenotypes. Dev. Neurosci. 17:1995;311-323.
54. Martin D. P., Wallace T. L., Johnson E. M. Jr. Cytosine arabinoside kills postmitotic neurons in a fashion resembling trophic factor deprivation: Evidence that a deoxycytidine-dependent process may be required for nerve growth factor signal transduction. J. Neurosci. 10:1990;184-193.
55. McGahon A. J., Martin S. J., Bissonnette R. P., Mahboubi A., Shi Y., Mogil R. J., Nishioka W. K., Green D. R. The end of the (cell) line: Methods for the study of apoptosis in vitro. Methods Cell. Biol. 46:1995;153-185.
56. Momparler R. L., Karon M., Siegel S. E., Avila F. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res. 36:1976;2891-2895.
57. Moura Neto V., Mallat M., Chneiweiss H., Premont J., Gros F., Prochiantz A. Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. I. Immunological and pharmacological properties. Brain Res. 391:1986;11-22.
58. Nakaya K., Chou S., Kaneko M., Nakamura Y. Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells. Jpn. J. Cancer Res. 82:1991;184-191.
59. Nooter K., Boersma A. W., Oostrum R. G., Burger H., Jochemsen A. G., Stoter G. Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br. J. Cancer. 71:1995;556-561.
60. Pardee A. B. G1 events and regulation of cell proliferation. Science. 246:1989;603-608.
61. Picksley S. M., Vojtesek B., Sparks A., Lane D. P. Immunochemical analysis of the interaction of p53 with MDM2; - Fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene. 9:1994;2523-2529.
62. Prasad K. N., Carvalho E., Kentroti S., Edwards-Prasad J., Freed C., Vernadakis A. Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev. Biol. Anim. 30A:1994;596-603.
63. Reiss M., Gamba-Vitalo C., Sartorelli A. C. Induction of tumor cell differentiation as a therapeutic approach: Preclinical models for hematopoietic and solid neoplasms. Cancer Treat. Rep. 70:1986;201-218.
64. Roberts-Lewis J. M., Marcy V. R., Zhao Y., Vaught J. L., Siman R., Lewis M. E. Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo. J. Neurochem. 61:1993;378-381.
65. Ronen D., Schwartz D., Teitz Y., Goldfinger N., Rotter V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ. 7:1996;21-30.
66. Ross D. D., Chen S. R., Cuddy D. P. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Cancer Res. 50:1990;2658-2666.
67. Rotter V., Aloni-Grinstein R., Schwartz D., Elkind N. B., Simons A., Wolkowicz R., Lavigne M., Beserman P., Kapon A., Goldfinger N. Does wild-type p53 play a role in normal cell differentiation. Semin. Cancer Biol. 5:1994;229-236.
68. Ryder E. F., Snyder E. Y., Cepko C. L. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21:1990;356-375.
69. Sachs L. Cell differentiation and bypassing of genetic defects in the suppression of malignancy. Cancer Res. 47:1987;1981-1986.
70. Schwenke K., Peterson H. P., Wangenheim K. H., Feinendegen L. E. Induction of differentiation in erythroleukemic K562 cells by gamma-irradiation. Leukocyte Res. 19:1995;955-961.
71. Shaulsky G., Goldfinger N., Peled A., Rotter V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;8982-8986.
72. Skladanowski A., Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmacol. 46:1993;375-382.
73. Soddu S., Blandino G., Citro G., Scardigli R., Piaggio G., Ferber A., Calabretta B., Sacchi A. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood. 83:1994;2230-2237.
74. Srinivasan R., Maxwell S. A. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region. Oncogene. 12:1996;193-200.
75. Supino R., Mariani M., Colombo A., Prosperi E., Croce A. C., Bottiroli G. Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells. Eur. J. Cancer. 28A:1992;778-783.
76. Taher A., Yanai N., Obinata M. Properties of incompletely immortalized cell lines generated from a line established from temperature-sensitive SV40 T-antigen gene transgenic mice. Exp. Cell. Res. 219:1995;332-338.
77. Tegtmeyer P., Ozer H. L. Temperature-sensitive mutants of simian virus 40: Infection of permissive cells. J. Virol. 8:1971;516-524.
78. Tewey K. M., Rowe T. C., Yang L., Halligan B. D., Liu L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 226:1984;466-468.
79. Toffoli G., Viel A., Bevilacqua C., Maestro R., Tumiotto L., Boiocchi M. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation. Leukocyte Res. 13:1989;279-287.
80. Tomkins C. E., Edwards S. N., Tolkovsky A. M. Apoptosis is induced in post-mitotic rat sympathetic neurons by arabinosides and topoisomerase II inhibitors in the presence of NGF. J. Cell Sci. 107:1994;1499-1507.
81. Truckenmiller M. E., Tornatore C., Wright R. D., Dillon-Carter O., Meiners S., Geller H. M., Freed W. J. A truncated SV40 large T antigen lacking the p53 binding domain overcomes p53-induced growth arrest and immortalizes primary mesencephalic cells. Cell Tissue Res. 291:1998;175-189.
82. Truckenmiller M. E., Dillon-Carter O., Tornatore C., Kulaga H., Takashima H., Freed W. J. Growth properties of neural cell lines immortalized with the tsA58 allele of SV40 large T antigen. Cell Transplant. 6:1997;231-238.
83. Vogelstein B. Cancer. A deadly inheritance [news; comment]. Nature. 348:1990;681-682.
84. Vogelstein B., Kinzler K. W. p53 function and dysfunction. Cell. 70:1992;523-526.
85. White L. A., Keane R. W., Whittemore S. R. Differentiation of an immortalized CNS neuronal cell line decreases their susceptibility to cytotoxic T cell lysis in vitro. J. Neuroimmunol. 49:1994;135-143.
86. Whittemore S. R., Neary J. T., Kleitman N., Sanon H. R., Benigno A., Donahue R. P., Norenberg M. D. Isolation and characterization of conditionally immortalized astrocyte cell lines derived from adult human spinal cord. Glia. 10:1994;211-226.
87. Whittemore S. R., White L. A. Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe. Brain Res. 615:1993;27-40.
88. Woodcock D. M., Fox R. M., Cooper I. A. Evidence for a new mechanism of cytotoxicity of 1-beta-D-arabinofuranosylcytosine. Cancer Res. 39:1979;1418-1424.
89. Xiang H., Hochman D. W., Saya H., Fujiwara T., Schwartzkroin P. A., Morrison R. S. Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16:1996;6753-6765.
90. Yan G. Z., Ziff E. B. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J. Neurosci. 15:1995;6200-6212.